Insulet (PODD) Enterprise Value (2010 - 2026)

Insulet (PODD) has reported Enterprise Value for 17 consecutive years, with $10.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 52.25% year-over-year to $10.0 billion; the trailing twelve-month figure through Jun 2026 stood at $10.0 billion (down 52.25% YoY), and the FY2025 full-year result was $19.3 billion, up 11.05% from the prior year.
• Enterprise Value declined to $10.0 billion in Q2 2026 per PODD's latest filing, from $14.1 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $21.6 billion in Q1 2023 and bottomed at $10.0 billion in Q2 2026.
• Historically, Enterprise Value has averaged $16.3 billion across 5 years, with a median of $16.3 billion in 2024.
• The sharpest annual moves came in 2025 and 2026: Enterprise Value soared 57.53% in 2025, then tumbled 52.25% in 2026.
• Over 5 years, Enterprise Value stood at $19.8 billion in 2022, then slipped by 26.9% to $14.5 billion in 2023, then grew by 20.11% to $17.4 billion in 2024, then rose by 11.05% to $19.3 billion in 2025, then tumbled by 48.04% to $10.0 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $10.0 billion, $14.1 billion, and $19.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.